IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques

Mucosal Immunology

Volumn 9, Issue 2, 2016, Pages 458-467

  Ortiz, A M ^a   Klase, Z A ^a,b   DiNapoli, S R ^a   Vujkovic Cvijin, I ^c   Carmack, K ^a   Perkins, M R ^a   Calantone, N ^a   Vinton, C L ^a   Riddick, N E ^a   Gallagher, J ^a   Klatt, N R ^a,d   McCune, J M ^c   Estes, J D ^e   Paiardini, M ^f   Brenchley, J M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 21; PROBIOTIC AGENT; ANTIRETROVIRUS AGENT; EMTRICITABINE; INTERLEUKIN DERIVATIVE; TENOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DRUG EFFICACY; DYSBIOSIS; ENZYME ACTIVITY; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; MACACA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TH17 CELL; THROMBOCYTE COUNT; VIRUS INHIBITION; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; GASTROINTESTINAL TRACT; IMMUNOLOGY; INTESTINE FLORA; MACACA NEMESTRINA; MUCOSAL IMMUNITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; ANTI-RETROVIRAL AGENTS; BACTERIAL TRANSLOCATION; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DYSBIOSIS; EMTRICITABINE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; IMMUNITY, MUCOSAL; INTERLEUKINS; MACACA NEMESTRINA; PROBIOTICS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TENOFOVIR; TH17 CELLS;

EID: 84961806957     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.75     Document Type: Article

References (46)

1. Lederman M.M, Funderburg N.T, Sekaly R.P, Klatt N.R, & Hunt P.W. Residual immune dysregulation syndrome in treated HIV infection. Adv. Immunol. 119, 51-83 (2013).
2. Volberding P.A, & Deeks S.G. Antiretroviral therapy and management of HIV infection. Lancet. 376, 49-62 (2010).
3. Marchetti G, Tincati C, & Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev. 26, 2-18 (2013).
4. Brenchley J.M, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006).
5. Estes J.D, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052 (2010).
6. Favre D, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5, e1000295 (2009).
7. Brenchley J.M, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood. 112, 2826-2835 (2008).
8. Raffatellu M, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421-428 (2008).
9. Peck A, & Mellins E.D. Precarious balance: Th17 cells in host defense. Infect. Immun. 78, 32-38 (2010).
10. Veldhoen M, Hocking R.J, Atkins C.J, Locksley R.M, & Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24, 179-189 (2006).
11. Goto Y, et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity. 40, 594-607 (2014).
12. Yang Y, et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature. 510, 152-156 (2014).
13. Ivanov, II et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 139, 485-498 (2009).
14. Ivanov, II et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 4, 337-349 (2008).
15. Littman D.R, & Pamer E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe. 10, 311-323 (2011).
16. Vujkovic-Cvijin I, et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Trans. Med. 5, 193ra191 (2013).
17. Klase Z, et al. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol. advance online publication, 14 January 2015; doi: 10.1038/mi.2014.128 (2015).
18. Klatt N.R, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J. Clin. Invest. 123, 903-907 (2013).
19. Korn T, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 448, 484-487 (2007).
20. Nurieva R, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 448, 480-483 (2007).
21. Yeste A, et al. IL-21 induces IL-22 production in CD4+ T cells. Nat. Commun. 5, 3753 (2014).
22. Micci L, et al. Paucity of IL-21-producing CD4(+) Tcells is associatedwith Th17 cell depletion in SIV infection of rhesusmacaques. Blood. 120, 3925-3935 (2012).
23. Pallikkuth S, et al. Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog. 9, e1003471 (2013).
24. Ma H.L, et al. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J. Immunol. 171, 608-615 (2003).
25. Pallikkuth S, et al. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in Tcells and NKcells and enhances B cell function without increasing immune activation or viral replication. Vaccine. 29, 9229-9238 (2011).
26. Byakwaga H, et al. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J. Infect. Dis. 210, 383-391 (2014).
27. Gaston M.A. Enterobacter: an emerging nosocomial pathogen. J. Hosp. Infect. 11, 197-208 (1988).
28. Perazella, M.A. Acute renal failure in HIV-infected patients: a brief review of common causes. Am. J. Med. Sci. 319, 385-391 (2000).
29. Alcantara S, et al. Thrombocytopenia is strongly associated with simian AIDS in pigtail macaques. J. Acquir. Immune Defic. Syndr. 51, 374-379 (2009).
30. Klatt N.R, et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5, 646-657 (2012).
31. Almeida J.R, et al. Superior control of HIV-1 replication by CD8+ Tcells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204, 2473-2485 (2007).
32. Betts M.R, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 107, 4781-4789 (2006).
33. Brenchley J.M, et al. High frequencies of polyfunctional HIV-specific Tcells are associated with preservation of mucosal CD4 Tcells in bronchoalveolar lavage. Mucosal Immunol. 1, 49-58 (2008).
34. Favre D, et al. Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36 (2010).
35. Kanwar B, Favre D, & McCune J.M. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr. Opin. HIV AIDS. 5, 151-157 (2010).
36. Spolski R, & Leonard W.J. Interleukin-21: a double-edged sword with therapeutic potential. Nat. Rev. Drug Discov. 13, 379-395 (2014).
37. Bettelli E, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441, 235-238 (2006).
38. Zhou L, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 453, 236-240 (2008).
39. Quintana F.J, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 453, 65-71 (2008).
40. Kristoff J, et al. Earlymicrobial translocation blockade reduces SIV-mediated inflammation and viral replication. J. Clin. Invest. 124, 2802-2806 (2014).
41. Lichterfeld M, et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med. 200, 701-712 (2004).
42. Appay V, et al. HIV-specific CD8(+) Tcells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192, 63-75 (2000).
43. Klatt N.R, et al. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol. 3, 387-398 (2010).
44. Viaud S, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 342, 971-976 (2013).
45. Iida N, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 342, 967-970 (2013).
46. Brenchley J.M, et al. Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections. Blood. 120, 4172-4181 (2012).